Business Archives - Green Market Report

StaffStaffDecember 13, 2018
daily_hit004-1280x533.png

4min150

It’s time for your Daily Hit of cannabis financial news for December 13, 2018.

On The Site

Harvest Health & Recreation, Inc. (CSE: HARV)  has formed a joint venture with Aina We Would (AWW), LLC for a real estate investment vehicle that plans to provide funding to purchase cannabis-related real estate assets. In addition to a Harvest subsidiary, AWW is made up of two family offices, Aina Advisors LLC and Stadlen Family Holdings, LLC.

Aina and Stadlen have both committed to fund or arrange up to $100 million to fund projects for the joint venture. The statement said that AWW plans to buy, develop and finance new construction projects, engage in land purchases, capital improvements and sale-leasebacks to Harvest and other operators in the cannabis industry.

HEXO Corp. (TSX: HEXO) (OTC: HYYDF) reported its financial results for the first quarter of the 2019 fiscal year with gross revenue of  C$6.7 million versus last year’s C$1.1 million for the same time period. The revenue figure includes C$5.2 million from legal adult-use cannabis sales during the first two weeks of legalization.

Still, the company delivered a net loss of C$14.7 million versus last year’s net loss of C$381,000. Hexo said that the increased loss was mainly due to higher expenses needed for expanding the scale of the operations as it prepared for the legalization of the adult-use market and the realization of stock-based compensation expenses in line with the increased headcount and market share price value of the company.

In Other News

Plus Products Inc. (CSE: PLUS) completed the acquisition of all the assets of California-based cannabis-infused baked goods brand GOOD CO-OP, INC. pursuant to the terms of an asset purchase agreement among the Company, Plus Products Holdings Inc., GOOD and the GOOD security holders’ agent. Under the terms of the agreement, the Company issued 357,464 subordinate voting shares to the shareholders and holders of simple agreements for future equity of GOOD at a valuation of approximately CAD$2,030,000. Of the 357,464 subordinate voting shares issued, 323,451 subordinate voting shares are subject to an earn-out as previously disclosed in the Company’s press release of December 3, 2018.

Treez closed its acquisition of Washington-based traceability software, Mister Kraken, which is used by more than 130 burgeoning cannabis producers and manufacturers in Washington state. Treez will be re-branding the Mr. Kraken product as Grow Treez.

Khiron Life Sciences Corp.  (TSXV: KHRN), (OTCQB: KHRNF) completed its acquisition of the Latin American Institute of Neurology and the Nervous System (“ILANS”). ILANS is one of the most respected, fastest growing, and largest health service network providers in Colombia and Latin America.


Video StaffVideo StaffDecember 13, 2018

1min480

Humboldt County in California has seen its fair share of boom and bust cycles. From gold mining to logging, this county continues to reinvent itself. Now it’s cannabis that is fueling the county and specifically the town of Eureka’s latest boom. Rob Holmlund, the Director of Community Development in Eureka California tells the Green Market Report how the area has been transformed by the cannabis industry that has brought meaningful jobs to the residents.


Debra BorchardtDebra BorchardtDecember 13, 2018
Harvest-1280x853.jpg

3min770

Harvest Health & Recreation, Inc. (CSE: HARV)  has formed a joint venture with Aina We Would (AWW), LLC for a real estate investment vehicle that plans to provide funding to purchase cannabis-related real estate assets. In addition to a Harvest subsidiary, AWW is made up of two family offices, Aina Advisors LLC and Stadlen Family Holdings, LLC.

Aina and Stadlen have both committed to fund or arrange up to $100 million to fund projects for the joint venture. The statement said that AWW plans to buy, develop and finance new construction projects, engage in land purchases, capital improvements and sale-leasebacks to Harvest and other operators in the cannabis industry.

As a part of the arrangement, Harvest will have the opportunity to get lease rates below current market providers and then source permanent financing for the properties it acquires. Harvest may also use AWW for its construction and real estate development needs.

In addition, Harvest said that it was has committed to lending AWW a minimum of up to $30 million in short-term financing to permit AWW to seek out acquisition projects. The company said that the goal of the short-term financing was so that they could move quickly on projects.  These funds will be replaced by permanent financing provided or sourced by Stadlen and Aina.

“AWW gives Harvest an excellent funding option for the development of cultivations, manufacturing facilities, and dispensaries,” said Harvest President Steve Gutterman.  “This new vehicle, combined with the approximate $290 million we raised in conjunction with our recent debt and equity financing transactions, affiliate roll-up and recently completed acquisitions leading up to and following our listing on the CSE, gives us one of the strongest balance sheets in the industry.”

Harvest owns more than 40 cannabis licenses with a domestic footprint that includes real estate, equipment and other assets in 11 states, including Arizona, Arkansas, California, Colorado, Florida, Maryland, Massachusetts, Nevada, North Dakota, Ohio and Pennsylvania.

“Real estate is the lifeblood of the cannabis economy and a huge piece of any company’s bottom line,” said Harvest Executive Chairman, Jason Vedadi. “With this partnership, AWW has been structured to turn a significant cost center into a potential profit driver and to become a potentially attractive source of financing for Harvest’s expected expansion.”


Debra BorchardtDebra BorchardtDecember 13, 2018
Hexo2.jpg

5min580

HEXO Corp. (TSX: HEXO) (OTC: HYYDF) reported its financial results for the first quarter of the 2019 fiscal year with gross revenue of  C$6.7 million versus last year’s C$1.1 million for the same time period. The revenue figure includes C$5.2 million from legal adult-use cannabis sales during the first two weeks of legalization.

Still, the company delivered a net loss of C$14.7 million versus last year’s net loss of C$381,000. Hexo said that the increased loss was mainly due to higher expenses needed for expanding the scale of the operations as it prepared for the legalization of the adult-use market and the realization of stock-based compensation expenses in line with the increased headcount and market share price value of the company.

“HEXO hit tremendous milestones in the weeks following the legalization of adult-use cannabis,” said HEXO’s CEO and co-founder Sebastien St-Louis. “The company continues to honor its commitment to executing on its plans, which has led to a significant portion of our first quarter’s $6.7 million in revenue generated in just two weeks and represents more than a 500% increase over last quarter.”

Hexo said that it sold approximately 1,110,000 total gram in the quarter versus 539,000 in total fiscal 2018. Despite the new adult-use market, the company still experienced a 2% increase over last quarter in its medical cannabis sales.

“HEXO’s first quarter financials highlight the remarkable pace of its adult-use cannabis sales and put HEXO on-track to generate significant revenue this year”, added Mr. St-Louis.

Adult Use Sales

Hexo said that its adult-use sales totaled C$5.1 million during the quarter, which is a 371% increase over the C$1.1 million of medical sales in the first quarter of 2018, and a 5% increase over the C$4.9 million of total medical sales in all of fiscal 2018.

The sales volume in the first quarter of 2019 was 952,223 gram equivalents sold. With a limited ability to sell other forms of cannabis, dried flower represented 81% of gram equivalents sold during the period.

The company reported that adult-use revenue per gram was approximately C$5.45. Hexo said that this was reflective of the bulk of sales attributed to dried flower which commands a competitive market sales price. The remaining balance was made up of oil sales which get a higher revenue per gram equivalent.

The company statement said that 90% of all adult-use sales were realized in Quebec through the SQDC with the remaining 10% derived in Ontario and British Columbia via the OCS and BCLDB respectively.

Medical Cannabis Sales

Even though the focus has been on the new adult-use cannabis market, medical sales continue to be an important part of the equation. Revenue increased 30% to C$1.4 million compared to C$1.1 million in the same period last year. Hexo said that the higher revenue was driven by increased sales volume as well as higher Elixir oil sales which get a higher revenue per gram when compared to dried gram sales. Sequentially, revenue increased 2% reflecting a lower revenue per gram on the dried flower sales which decreased $0.22/gram due to the current period’s sales mix of products.

The sales volume for medical cannabis increased 30% to 157,504 gram equivalents, compared to 120,844 in the same prior year period, due to an increase in oil-based products as the product mix purchased by customers shifted towards smoke-free alternatives. Total dried grams sold increased 10% when compared to the same prior year period. Revenue per gram equivalent remained at $9.12 as compared the same prior year period. On a sequential basis, sales volume collectively increased 3% across both dried and oil sales.

Geographical sales in Ontario and Quebec increased 8% and 16% respectively.

 

 


Sean HockingSean HockingDecember 13, 2018
Unknown-25-150x150-2.jpeg

26min290

Here’s their full list of towns saying no thankyou to regulated cannabis

SOURCE: https://www.nj.com/expo/news/erry-2018/12/64cb95fd7e1151/nj-is-moving-toward-legal-weed.html


William SumnerWilliam SumnerDecember 12, 2018
daily_hit004-1280x533.png

5min380

It’s time for your Daily Hit of cannabis financial news for December 12, 2018

On the Site

Aphria Continues International Push With Paraguay Despite Criticism

Aphria Inc.  (TSX: APHA) (NYSE: APHA) continues to forge ahead with its international expansion despite coming under fire from a short seller recently. Recently, Hindenburg Investment Research and Quintessential Capital Management released their short report on the company and questioned some of Aphria’s overseas investments causing the stock to plunge and triggering price target reductions by analysts.

Senate Votes To Pass 2018 Farm Bill, Next Stop Is The House

The 2018 Farm Bill has passed in the U.S. Senate with a vote of 87-13. The legislation goes to the House next for a vote and if it passes there, it will head to the President’s desk to be signed. Hemp will be switched for review to the Department of Agriculture and away from the Justice Department.

LeafLink Says Alaska, Maryland Most Expensive Place To Buy Cannabis

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

In Other News

GTEC Holdings Ltd.

GTEC Holdings Ltd. (TSXV: GTEC), a vertically integrated cannabis company, announced today that it had been approved for up-listing of trading onto the OTCQB Venture Market. Effective immediately, the company will start trading on the OTCQB under the symbol GGTTF.

mCig Inc.

mCig Inc. (OTCMKTS: MCIG) announced that Cal Acres Inc., a California company with majority ownership by MCIG, has received its Type-11 Distribution Temporary license from the state of California. Though the company has not completed construction on its distribution facility, Cal Acres may use its license to purchase and store product in a rented facility for the time being. Cal Acres expects that it will receive its cultivation and manufacturing licenses over the next several weeks. “Obtaining a temporary distribution license allows us to interact with the thousands of California Cultivators, Manufacturers, and Distributors… It’s a new launching pad for our future brands,” said Paul Rosenberg, CEO of MCIG Inc.

Mary’s Tech CA

Mary’s Tech CA has announced the opening of a 1,500 square foot manufacturing and distribution facility in Grover Beach, California. The climate-controlled facility utilizes proprietary automation equipment and a high-performance liquid chromatography machine for in-house testing. “We are pleased to officially be operating under our own BCC manufacturing and distribution license and to be in full control of the operations pipeline,” said Lynn Honderd, CEO of Mary’s Tech CA, Inc. “Partnering with EVIO Labs, a premier provider of analytical testing and research, as well as utilizing a robust distribution team, will result in improved efficiencies across the board. Ensuring that patients and consumers in California have consistent access to clean, reliable and accurately dosed products is the utmost importance to us.”


William SumnerWilliam SumnerDecember 12, 2018
Alaska.jpg

4min4070

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

Examining the wholesale landscape of some of the most mature cannabis markets in the United States, the guide looks at the average wholesale price of cannabis in eight states: Alaska, Arizona, California, Colorado, Maryland, Nevada, Oregon, and Washington. The product types covered by the report include concentrates, cartridges, edibles, flower, and pre-rolls.

Although the report does not dive into the specifics of why one state is more expensive than another, the authors speculate that the Alaska and Maryland’s high prices are due to the states having a low number of cannabis cultivators. In the two states where cannabis is cheapest, Washington and Oregon, there is currently a glut of cannabis cultivators; leading to low prices and oversupply.

“As the standard wholesale marketplace for the industry’s leading brands, we are able to provide crucial market information to cannabis retailers and brands, which will help inform their plans for 2019,” said LeafLink Co-Founder and CEO Ryan G. Smith in a statement. “As more states like Massachusetts, Connecticut, Pennsylvania, and Michigan continue to establish wholesale operations, we will be able to provide a larger scope of market activity to further empower the LeafLink community, as well as the industry at large.”

Nationwide, the average price for a pound of cannabis flower is $2,124 per pound, while a gram of pre-rolls costs around $5.66 per gram. The average price for cannabis concentrates costs approximately $26.07 per gram and cartridges are priced at around $39.55 per gram. Edible cannabis products, on average, cost around $0.20 per milligram.

When taken on a state-by-state level, cannabis prices start to vary. With regards to cannabis consumer preferences, the report found that consumers prefer products in the lowest 25% price range. The exception to this was pre-rolls. On average, consumers preferred pre-roll products in the 25%-49.99% price range.

The report also examined the relationship between pricing and discounted sales. On average, approximately 16% of the products sold through LeafLink’s platform have a discounted price. Across all eight states examined, discounted products generated 3% more sales than regularly priced products.

The discount effect is magnified when combined with larger sales campaigns. During the last year, LeafLink ran two sales promotions, one in the month leading up to 4/20 (dubbed 3/20) and one in July called 7/10; which is a considered an industry-wide “holiday” for concentrates.

When combined with those larger sales campaigns, discounted products generated 37% more sales on 3/20 and 38% more sales on 7/10. This seems to suggest that cannabis retailers stand to significantly boost their sales numbers by combining sales promotions with discounted cannabis products.


Debra BorchardtDebra BorchardtDecember 12, 2018
paraguay.jpg

9min730

Aphria Inc.  (TSX: APHA) (NYSE: APHA) continues to forge ahead with its international expansion despite coming under fire from a short seller recently. Recently, Hindenburg Investment Research and Quintessential Capital Management released their short report on the company and questioned some of Aphria’s overseas investments causing the stock to plunge and triggering price target reductions by analysts.

On Wednesday, Aphria said it signed a Letter of Intent with Insumos Medicos S.A.  a Paraguayan pharmaceutical manufacturing, import, and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.

“Latin America continues to represent an important growth opportunity within the global medical cannabis industry, and we are excited to be among the first to enter the rapidly emerging market in Paraguay,” said Jakob Ripshtein, President of Aphria. “Our strategic partner, Insumos, is well-positioned to establish a leading presence for the Company’s products throughout the country. Aphria will continue to expand its footprint in the most strategic markets in Latin America and around the world through its diversified approach to innovation, partnerships, and expansion.”

According to Aphria, Insumos is a distributor of pharmaceuticals to hospitals within Paraguay. Insumos has the network, relationships, and reach to bring Aphria’s products to patients in need across the country. As part of the proposed agreement, Insumos will undertake the registration of Aphria’s products with Paraguay’s Ministry of Public Health and Social Welfare and appropriate licensing for the import of medical cannabis.

The company said that once the deal is closed Paraguay will become the third market in Latin America, following Argentina and Colombia in which Aphria products will be distributed.

Short Seller Response

With regards to the short seller report, Aphria said in a statement, “Investors should exercise caution in relying on the misrepresentations and distortions contained in the report and recognize that, by their own admission, Hindenburg Research “…stands to realize significant gains in the event that the price of any stock covered herein declines.”

The company went on to add, “The report makes reference to the Company’s LATAM acquisition which closed on September 27, 2018. In connection with this transaction, the Board of Directors of Aphria confirmed that it received financial advice and a fairness opinion from a reputable firm that the consideration to be offered by Aphria in respect of the transaction was fair, from a financial point of view to Aphria and its shareholders.”

LATAM Defence

Aphria also fired back with regards to the points that Hindenburg made about the LATAM investments. The company said that its Board of Directors received financial advice and a fairness opinion from Cormark Securities Inc., the company’s independent and qualified financial advisor, which said the transaction was fair, from a financial point of view to Aphria. Aphria also said that it believes that the purchase price paid under the transaction was comparable with similar Latin America acquisitions by other large-cap, Canadian licensed producers.

The company also said that it retained counsel in each jurisdiction that completed extensive legal due diligence on the assets, licenses and businesses in each jurisdiction. Aphria said it sent executives to Colombia, Argentina, Jamaica, and Brazil to conduct due diligence regarding the assets to be acquired which included management meetings. Plus the company said it made site visits in each country and met with local authorized representatives.


Debra BorchardtDebra BorchardtDecember 12, 2018
senate.jpg

8min695114

This story was updated on December 11, 2018.

The 2018 Farm Bill has passed in the U.S. Senate with a vote of 87-13. The legislation goes to the House next for a vote and if it passes there, it will head to the President’s desk to be signed. Hemp will be switched for review to the Department of Agriculture and away from the Justice Department.

Language that would ban people with felony convictions from working in the hemp industry was amended so that the ban would end 10 years after this legislation is passed.

Hemp farmers and CBD-related companies will benefit the most from the passage of the Farm Bill. CBD or cannabidiol is derived from the cannabis plant but has none of the psychotropic effects of THC. In The Farm Bill, there is language that amends the Controlled Substances Act and legalizes CBD. The passage reads as follows:

‘(B) The term ‘marihuana’ does not include— 10 ‘‘(i) hemp, as defined in section 297A of the 11 Agricultural Marketing Act of 1946; or 12 ‘‘(ii) the’’. 13 (b) TETRAHYDROCANNABINOL.—Schedule I, as set 14 forth in section 202(c) of the Controlled Substances Act 15 (21 U.S.C. 812(c)), is amended in subsection (c)(17) by 16 inserting after ‘‘Tetrahydrocannabinols’’ the following: ‘‘, 17 except for tetrahydrocannabinols in hemp (as defined 18 under section 297A of the Agricultural Marketing Act of 19 1946)’’.

It is expected to be removed from the DEA’s schedule 1 list to schedule 5, which is the lowest level and would lift the DEA’s restrictions. CBD products have already begun to explode in the marketplace in anticipation of these changes.

“The cannabis industry is closely watching the outcome of the Farm Bill. And while we are seeing a lot of startups try to move in, nobody is better suited to operate in this market than experienced licensed cannabis manufacturers,” said Nancy Whiteman, founder, and CEO of Wana Brands, makers of cannabis-infused products.” Marijuana-infused producers have been perfecting precise dosing, testing, and supply chains for the past decade, and these companies will lead the way in the next generation of CBD products.”  Wana Brands has the leading THC gummy in Colorado, but it will be producing a CBD only version in 2019.

GW Pharmaceuticals (NASDAQ: GWPH) had its drug Epidiolex approved by the FDA earlier this year and removed from the schedule 1 category. This medicine though has a very high level of CBD, unlike the mass-market versions which have fairly low levels of CBD. Plus, patients know exactly what they are getting with the prescription drug. Consumers purchasing mass market CBD products generally have no idea how much CBD is in the product or how it was manufactured.

“What is known about CBD is only the tip of the iceberg,” said Lisa Richards, co-CEO, L’eela CBD Body Care:  Consumers are just starting to understand the benefits of CBD, and when the floodgates open, they are going to need to be educated and be their own advocates. Hemp may be federally legal with the passage of the Farm Bill. However, more importantly, where is it sourced? How is it processed? The passage of the Farm Bill is only the first chapter.” All L’eela products are made with hemp that is grown and processed in the United States.

Many companies use CBD oil that is made from Chinese hemp. In 2017, the FDA issued warning letters to several CBD companies. The products didn’t contain the level of CBD that they claimed or the companies made marketing claims about health conditions for which there was no scientific proof. With these new changes, the industry has a better chance of creating standards so that consumers can make educated choices.

The Farmers

In addition to boosting the product sales of CBD brands, the Farm Bill will benefit hemp farmers. Chase Terwilliger, CEO of CBDistillery, a Balanced Health Botanicals brand said that the biggest benefit to hemp farmers is that they will be able to buy crop insurance. Most farmers have this type of insurance to protect them from weather or anything else that could hurt a harvest. Hemp has only been approved from a research standpoint and so it wasn’t eligible for crop insurance.

There is a big desire to shift some of the Chinese production of hemp back to the United States. One reason Senator McConnell has been supporting the inclusion of hemp in the Farm Bill is that it gives tobacco farmers in Kentucky a way to keep their farms productive.

“Hemp is fairly inexpensive to grow and maintain,” he said. “But we hear from farmers that harvesting is a big challenge because the farm equipment isn’t designed to handle the product which is extremely fibrous.” Terwilliger also noted that hemp is a very absorbent plant and with China’s pollution, their hemp plants tend to have heavy metal exposure. “Consumers deserve a high-quality hemp plant,” he said.

Farmers have already begun carving out small sections of their farms to begin testing hemp. 100 acres was seen as a little risk. Now, it is expected that many farmers will quickly make the switch if the plant is legal.

Options

Terwilliger also noted that like traditional agriculture, there could soon be hemp futures. Farmers like futures contracts on their crops as it locks in a price. Options traders will buy and sell these instruments like any other agricultural product. “It will turn into a commodity that futures can trade on,” he said.


Sean HockingSean HockingDecember 11, 2018
border.jpg

10min500
In October 2018, the recreational possession and use of cannabis became legal throughout Canada pursuant to The Cannabis Act. While the people and state legislatures of 10 U.S. states have similarly moved to legalize the recreational use of cannabis, it still remains a Schedule I controlled substance under U.S. federal law.

Thus, because the laws and rules governing immigration benefits and border crossings into the U.S. exist at the federal level, even the possession of marijuana continues to be unlawful as pertains to foreign nationals seeking to enter the country.

In the wake of this major shift in legal framework for our neighbors to the north, it is critical that U.S. employers and Canadian nationals be aware of the rules at the border and be smart about their interactions with U.S. Customs and Border Protection (“CBP”) officials.

To date, CBP has issued only one statement on this issue, in which it took the following position: “A Canadian citizen working in or facilitating the proliferation of the legal marijuana industry in Canada, coming to the U.S. for reasons unrelated to the marijuana industry will generally be admissible to the U.S. However, if a traveler is found to be coming to the U.S. for reason related to the marijuana industry, they may be deemed inadmissible.”

In this article, we offer some background information, considerations and tips to keep in mind when deciding on whether to send a particular individual into the U.S. for business purposes and what types of questions may be posed by a CBP officer.

By way of background, CBP officers screen and inspect all foreign nationals entering the United States at authorized ports of entry to determine that they have the authorization to enter and that they will otherwise comply with the terms of the person’s visa classification and the laws of the U.S. CBP officers enjoy nearly unfettered discretion when it comes to admitting persons into the country and it can be quite difficult to challenge their decisions. Moreover, CBP officers are trained to look for suspicious conduct or information and may even use certain tactics in an attempt to elicit incriminating information from a person that presents herself for inspection and admission into the U.S. Therefore, it is important that visitors be smart, alert and savvy when engaging with a CBP officer. They should answer questions succinctly and truthfully. To emphasize, lying or misrepresenting to CBP can have very serious immigration consequences, including not being allowed into the U.S. and potentially jeopardizing the individual’s eligibility for future immigration benefits and visas.

Below are some suggestions for employees traveling to the U.S.:

  • While it may seem obvious, it warrants emphasis: the individual may have absolutely no cannabis or paraphernalia on her person or in her car. This includes socio-political t-shirts, bumper stickers and the like, as these may serve to give a reason to suspect marijuana use or possession and will certainly set the wrong tone.
  • Be aware of your social media content, as CBP officers can attempt to access social media and may even confiscate electronic devices and attempt to gain access that way (you do not have to give them passwords, but it does not mean that they may not try and could retain your device for a period of time even after letting you go).
  • CBP officers may use certain tactics to elicit incriminating information: despite what an officer may say, they cannot drug test you on the spot; they cannot detain you indefinitely; and they cannot administer a lie detector test.

Below are some sample scenarios at the U.S.-Canada border and considerations:

The most likely way an issue would arise is direct and straightforward: The CBP officer asks if the person has ever smoked or does smoke marijuana. The individual answers ‘yes.’ The CBP officer then denies her entry on the basis that they now have reason to believe that the person will violate the laws of the U.S. once they are admitted because, from a U.S. legal perspective, the person has confirmed that they have engaged in illicit activity and, thus, might do so once inside the U.S. Importantly, this would not likely result in a permanent bar to entry, but it could be recorded in the CBP database and could render future attempts to enter the country problematic.

Bars to entry into the U.S.: If there is a formal finding of inadmissibility based on criminal grounds (e.g., drug trafficking or prior drug conviction or admitting to having committed acts that constituted a crime at the time of commission), the individual could become subject to a bar to reentry into the U.S.

  • One way this could play out is that a CBP officer could get the individual to explicitly admit to having smoked marijuana before it was legalized in Canada (i.e., pre-October 2018). Through the right line of questioning that gets the person to admit to having committed the elements of the statute prohibiting marijuana possession/use in effect at the time of the conduct and appraisal of that law, the individual would then be deemed inadmissible (as having committed a drug crime) and would not be allowed into the U.S. unless and until they obtain an approved ‘waiver of inadmissibility.’

In light of the foregoing, employers should use their judgment in considering whom to send for cross-border work engagements. If you believe an employee may have an issue or is not sophisticated enough to appropriately engage with the CBP officer, our attorneys can work with you in advance to best navigate the complexities of the U.S. immigration law system and find an appropriate solution.

Authored By: Shaun Staller

| Dec 10, 2018 |

Source: http://knowingimmigrationlaw.com/author/staller1/

Shaun Staller is a business immigration attorney with broad international experience, providing services in multiple languages. He counsels individuals and businesses across a variety of industries in adeptly navigating the complex and ever-changing U.S. immigration system in order to achieve their real-world goals. He focuses his practice on employment-based visas and related compliance in both immigrant and nonimmigrant visa categories and also works closely with foreign entrepreneurs seeking to start new ventures or to invest in the U.S. Additionally, Shaun advises companies on employee documentation and compliance requirements and represents clients before federal agencies, including U.S. Citizenship and Immigration Services, the Department of Labor and the Department of State.

Shaun also provides legal counsel on family-based immigration matters and admissibility issues, including waivers of grounds of inadmissibility. He is also experienced in handling asylum applications.

More at https://www.bipc.com/shaun-k.-staller



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 18 hours

Please help support Go visit our Patreon page

@GreenMarketRpt – 20 hours

$HARV.CN $HTHHF Harvest Forms $100 Million Joint Venture For Real Estate Projects

@GreenMarketRpt – 20 hours

$HEXO $HYYDF ⁦@Hexocorp⁩ Hexo Reports C$5.2 Million For Just Two Weeks Of Adult Use Cannabis Sales #earnings…

Back to Top

You have Successfully Subscribed!